Randomized Phase II Trial of Liposomal Cytarabine and Daunorubicin With or Without Pomalidomide in Newly Diagnosed Acute Myeloid Leukemia Myelodysplasia-Related

Authors

• Daniel T Peters
• Kristin Koenig
• Anastasia Ivanova
• Jiajun He
• Gail J Roboz
• Uma Borate
• Jesus Gonzalez-Lugo
• Tara Lin
• Bayard Powell
• Emily Curran
• Michael Hochman
• Daniel Reed
• Angela Nichols
• Lauren Higgins
• Allison McKinney
• Alice Mims
• William Carson
• E Claire Dees
• Richard F Little
• Howard Streicher
• Christopher Hourigan
• Leo Luznik
• Ivana Gojo
• Joshua F Zeidner

Language

English

Publication Date

9-24-2026

Journal

Haematologica

DOI

10.3324/haematol.2026.301466

PMID

42779304

Abstract

Not available.

Published Open-Access

yes

Recommended Citation

Peters, Daniel T; Koenig, Kristin; Ivanova, Anastasia; et al., "Randomized Phase II Trial of Liposomal Cytarabine and Daunorubicin With or Without Pomalidomide in Newly Diagnosed Acute Myeloid Leukemia Myelodysplasia-Related" (2026). Faculty, Staff and Students Publications. 8139.
https://digitalcommons.library.tmc.edu/baylor_docs/8139